TeraPore Launches IsoBlock® VF Viral Filtration Product Line with Proprietary Membrane Technology that Delivers Consistent Results

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–TeraPore Technologies, an innovator in nanofiltration membranes, has commercially launched the flagship IsoBlock® VF product line for parvovirus removal from biopharmaceuticals. During evaluations at multiple customer sites across different novel antibody constructs, IsoBlock VF has demonstrated robust and consistent performance. With both mammalian parvoviruses and surrogate…
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks